Avid Bioservices Appoints Oksana Lukash as Vice President, People
November 16 2022 - 08:05AM
GlobeNewswire Inc.
Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics
contract development and manufacturing organization (CDMO) working
to improve patient lives by providing high quality development and
manufacturing services to biotechnology and pharmaceutical
companies, today announced the appointment of Oksana Lukash, as
vice president, people. Ms. Lukash has more than 20 years of human
resources experience with both established and entrepreneurial
organizations across a range of industries.
Prior to joining Avid, Ms. Lukash served as vice
president, people & culture at Oncocyte Corporation, a
precision diagnostics company. During her three year tenure with
the company, she was instrumental in driving three acquisitions and
the successful integration of the acquired entities. Ms. Lukash is
also credited with growing Oncocyte’s employee base by nearly 600%,
with less than 5% turnover and securing recognition for the company
multiple times as a “Best Places to Work” locally and national.
Throughout her career, she has also held senior human resources
roles with several other leading life science companies including
Avanir Pharmaceuticals, Agendia, and Clarient. Ms. Lukash is also
an active member of Chief network, a private network built to drive
more women into positions of leadership, as well as a vice chair of
the board for the Dee Dee Jackson Foundation, an organization that
connects those who have a commonality in grief.
“We are excited to welcome Oksana and her track
record of successfully building and supporting workforces and
creating best-in-breed cultures at a range of leading companies
within the life science industry to Avid,” said Nick Green,
president and chief executive officer of Avid Bioservices. “Her
strategic, tech-savvy approach is an ideal fit for the company and
we look forward to the contributions that she will make in
continuing to enhance our team and optimize the workplace in which
they drive Avid’s success.”
About Avid Bioservices,
Inc.
Avid Bioservices (NASDAQ:CDMO), an S&P
SmallCap 600 company, is a dedicated contract development and
manufacturing organization (CDMO) focused on development and CGMP
manufacturing of biologics. The company provides a comprehensive
range of process development, CGMP clinical and commercial
manufacturing services for the biotechnology and biopharmaceutical
industries. With 29 years of experience producing monoclonal
antibodies and recombinant proteins, Avid's services include CGMP
clinical and commercial drug substance manufacturing, bulk
packaging, release and stability testing and regulatory submissions
support. For early-stage programs the company provides a variety of
process development activities, including upstream and downstream
development and optimization, analytical methods development,
testing and characterization. The scope of our services ranges
from standalone process development projects to full development
and manufacturing programs through
commercialization. www.avidbio.com
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From May 2023 to Jun 2023
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Jun 2022 to Jun 2023